{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:58:00Z","timestamp":1776275880372,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00248","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T07:49:41Z","timestamp":1590133781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials"],"prefix":"10.3389","volume":"7","author":[{"given":"Eugenie R.","family":"Lumbers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Delforce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty G.","family":"Pringle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock."},{"key":"B3","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume-title":"Drug Dev Res.","author":"Gurwitz","year":"2020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"ciaa329","DOI":"10.1093\/cid\/ciaa329","article-title":"Is there an association between COVID-19 mortality and the renin-angiotensin system-a call for epidemiologic investigations","author":"Hanff","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B7","unstructured":"The Heart Failure Society of America The American College of CardiologyPatients Taking ACE-i and ARBs Who Contract COVID-19 Should Continue Treatment, Unless Otherwise Advised by Their Physician2020"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume-title":"Circ Res.","author":"Zhang","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.23.20076661","article-title":"The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19): a meta-analysis","author":"Ghosal","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1038\/jp.2008.149","article-title":"Angiotensin II in apoptotic lung injury: potential role in meconium aspiration syndrome","volume":"28","author":"Uhal","year":"2008","journal-title":"J Perinatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.biocel.2011.11.019","article-title":"Angiotensin signalling in pulmonary fibrosis","volume":"44","author":"Uhal","year":"2012","journal-title":"Int J Biochem Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1101\/2020.02.19.956946","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19970","DOI":"10.1073\/pnas.0908837106","article-title":"Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor","volume":"106","author":"Wu","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1874357901004010076","article-title":"Understanding human coronavirus HCoV-NL63","volume":"4","author":"Abdul-Rasool","year":"2010","journal-title":"Open Virol J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1099\/vir.0.2008\/003962-0","article-title":"Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2","volume":"89","author":"Mathewson","year":"2008","journal-title":"J Gen Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/357420a0","article-title":"Human aminopeptidase N is a receptor for human coronavirus 229E","volume":"357","author":"Yeager","year":"1992","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.116.07884","article-title":"Examining EXAMINE for an interaction with angiotensin-converting enzyme inhibition","volume":"68","author":"Wilson","year":"2016","journal-title":"Hypertension."},{"key":"B22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/fvl.10.4","article-title":"Renin-angiotensin system in human coronavirus pathogenesis","volume":"5","author":"Wevers","year":"2010","journal-title":"Future Virol."},{"key":"B23","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume-title":"Allergy.","author":"Zhang","year":"2020"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1101\/2020.02.06.20020974","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","volume-title":"J Travel Med.","author":"Diaz","year":"2020"},{"key":"B26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40635-015-0044-3","article-title":"Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental acute respiratory distress syndrome","volume":"3","author":"Zambelli","year":"2015","journal-title":"Intensive Care Med Exp."},{"key":"B27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/1381612033455431","article-title":"The pulmonary renin-angiotensin system","volume":"9","author":"Marshall","year":"2003","journal-title":"Curr Pharm Des."},{"key":"B28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1183\/09031936.00015612","article-title":"Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis","volume":"42","author":"Uhal","year":"2013","journal-title":"Eur Respir J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"B31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","article-title":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II","volume":"47","author":"Yamamoto","year":"2006","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","article-title":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice","volume":"75","author":"Oudit","year":"2007","journal-title":"Cardiovasc Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"F812","DOI":"10.1152\/ajprenal.00655.2013","article-title":"Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity","volume":"306","author":"Mori","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","author":"Ziegler","year":"2020","journal-title":"Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jviromet.2008.10.022","article-title":"Human airway epithelial cell culture to identify new respiratory viruses: coronavirus NL63 as a model","volume":"156","author":"Banach","year":"2009","journal-title":"J Virol Methods."},{"key":"B39","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","article-title":"Age- and gender-related difference of ACE2 expression in rat lung","volume":"78","author":"Xie","year":"2006","journal-title":"Life Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature."},{"key":"B42","doi-asserted-by":"publisher","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/jcpt.12625","article-title":"Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites","volume":"43","author":"Chen","year":"2018","journal-title":"J Clin Pharm Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","article-title":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications","volume":"30","author":"Soro-Paavonen","year":"2012","journal-title":"J Hypertens."},{"key":"B45","doi-asserted-by":"publisher","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am J Physiol Cell Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ."},{"key":"B47","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/216762a0","article-title":"Conversion of angiotensin I to angiotensin II","volume":"216","author":"Ng","year":"1967","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1161\/01.CIR.0000094733.61689.D4","article-title":"Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation."},{"key":"B51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin Pharmacokinet."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00248\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T07:49:45Z","timestamp":1590133785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00248\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":51,"alternative-id":["10.3389\/fmed.2020.00248"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00248","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"article-number":"248"}}